Detalhe da pesquisa
1.
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
Osteoporos Int
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565690
2.
Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
Osteoporos Int
; 35(3): 451-468, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37955683
3.
Fracture prediction in rheumatoid arthritis: validation of FRAX with bone mineral density for incident major osteoporotic fractures.
Rheumatology (Oxford)
; 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092036
4.
The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis.
Osteoporos Int
; 34(1): 1-9, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282342
5.
Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year.
Osteoporos Int
; 34(3): 479-487, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36562788
6.
Primary hyperparathyroidism and fracture probability.
Osteoporos Int
; 34(3): 489-499, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525071
7.
A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis.
Osteoporos Int
; 34(3): 429-447, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651943
8.
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Osteoporos Int
; 34(8): 1283-1299, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351614
9.
An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS.
Qual Life Res
; 32(4): 1199-1208, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495384
10.
FRAX Adjustment by Trabecular Bone Score with or Without Bone Mineral Density: The Manitoba BMD Registry.
J Clin Densitom
; 26(3): 101378, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37137791
11.
Prospective Study of Ageing Trajectories in the European DO-HEALTH Study.
Gerontology
; 69(1): 57-64, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443250
12.
Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France-results from the ICUROS study.
Osteoporos Int
; 33(3): 625-635, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642813
13.
Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures.
Osteoporos Int
; 33(12): 2507-2515, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161339
14.
Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).
Osteoporos Int
; 33(1): 57-66, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596704
15.
FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study.
Osteoporos Int
; 33(7): 1457-1463, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175395
16.
Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials.
Osteoporos Int
; 33(11): 2297-2305, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833956
17.
Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age 75 to 90.
Calcif Tissue Int
; 111(3): 288-299, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750934
18.
Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries.
BMC Geriatr
; 22(1): 174, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236290
19.
Management of patients at very high risk of osteoporotic fractures through sequential treatments.
Aging Clin Exp Res
; 34(4): 695-714, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332506
20.
Novel formulations of oral bisphosphonates in the treatment of osteoporosis.
Aging Clin Exp Res
; 34(11): 2625-2634, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331798